Related Experiment Video

Updated: Aug 13, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

STAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells

Mingsheng Zhang1, Yunfeng Zhou, Conghua Xie

  • 1Department of Cancer Radio-Chemotherapy, Wuhan University Zhongnan Hospital and Cancer Research Center, 169 Donghu Road, Wuhan, Hubei 430071, China. zms75@163.com <zms75@163.com>

Cancer Letters
|January 3, 2006
PubMed

Insights

RNA interference effectively inhibited colon cancer cell growth by targeting STAT6. This study highlights STAT6 signaling as a potential target for colon cancer therapy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • RNA interference (RNAi) is a powerful technique for gene function analysis.
  • The STAT6 signaling pathway's role in colon cancer requires further elucidation.

Purpose of the Study:

  • To investigate the effect of STAT6 knockdown on colon cancer cell behavior.
  • To explore STAT6 as a potential therapeutic target in colon cancer.

Main Methods:

  • Utilized short hairpin RNAs (shRNAs) to specifically knock down STAT6 transcription.
  • Analyzed the impact of STAT6 inhibition on cell proliferation, cell cycle, and apoptosis in HT-29 colon cancer cells.

Main Results:

  • Specific shRNAs successfully reduced STAT6 transcription in HT-29 cells.
  • STAT6 knockdown led to inhibited cell proliferation and G1/S phase arrest.
  • Targeting STAT6 induced apoptotic cell death in colon cancer cells.

Conclusions:

  • STAT6 signaling is implicated in regulating cell proliferation and apoptosis in colon cancer.
  • STAT6 represents a promising target for developing novel colon cancer therapies.

More Related Videos

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells06:13

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells

Published on: January 16, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...